InvestorsObserver is giving SQZ Biotechnologies Co (SQZ) an Analyst Rating Rank of 73, meaning SQZ is ranked higher by analysts than 73% of stocks. The average price target for SQZ is $35.25 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating SQZ a Strong Buy today. Find out what this means to you and get the rest of the rankings on SQZ!